About Alcami
Alcami is a Healthcare company based in Wilmington (United States) founded in 2016, and was acquired by GHO Capital Partners in November 2022. End-to-end small molecule development and manufacturing are provided for pharmaceuticals. Alcami has completed 3 acquisitions, including Alcami, Masy BioServices and Triangle Pharmaceuticals. Its chief executive, as recorded, is Stephan Kutzer. Alcami offers products and services including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is Alcami Corporation. Its competitors include Asymchem, Aptuit and Continuus Pharma; 2 of its 3 listed competitors have raised funding.
Company details
Alcami was established in 2016 through the merger of AAIPharma and Cambridge Major Laboratories. Small molecule development and manufacturing solutions are delivered to pharmaceutical companies in the outsourcing sector. Services encompass formulation, analytical and biopharmaceutical development, analytical testing, oral dose and parenteral manufacturing for final drug products, API manufacturing, as well as packaging and labelling. Operations are headquartered in Wilmington, United States.
- Headquarters Wilmington, United States
- Stage Acquired
- SectorsHealthcare
- Website alcaminow.com
- Social LinkedIn
- Acquired by GHO Capital Partners (Nov 2022)
- Legal Name Alcami Corporation
- InvestorsMadison Dearborn Partners
& 2 more
- Investments & AcquisitionsAlcami
& 2 more
- Acquired by
Products & Services of Alcami
Alcami offers a comprehensive portfolio of products and services, including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Services for sterile fill-finish and oral solid dose production.
Testing for analytical and microbiological needs in pharma.
Secure cGMP storage with calibration and validation support.
Investors in Alcami
Alcami has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Madison Dearborn Partners, GHO Capital and The Vistria Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward key sectors by MDP. | mdcp.com | Chicago, United States | ||
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom | ||
A private investment firm focused on essential industries is operated. | 2013 | vistria.com | Chicago, United States |
Investor details for Alcami
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alcami
32 people are tracked at Alcami (24 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Stephan Kutzer | CEO | Leadership |
Elliott Franco | VP, Lab Operations, RTP | Leadership |
Katie Schlipp | President, Laboratory Operations | Leadership |
Mark Petyak | Director Development And Technical Services | Leadership |
Tom Merola | Director, Engineering And Maintenance | Leadership |
David Belliveau | Director Of Facilities | Leadership |
Mark Dooley | Director: Business Applications | Leadership |
Casey Franklin | Vice President, Business Development | Leadership |
Rachel Flaim | Senior Talent Acquisition Partner | Leadership |
Sam Trimnal | Vice President, Quality Manufacturing, Regulatory And Pharma Storage | Leadership |
Scott Jedrey | Vice President, Oral Solid Dose Operations | Leadership |
Tariq Jamal | Chief Information Officer | Leadership |
Tyler Ewald | VP, Sterile Operations | Leadership |
Patrick Walsh | Interim CEO & Board Chair | Leadership |
Rose - Marie Nelson | Chief Human Resources Officer | Leadership |
Jamie Iudica | President, Drug Product / Chief Manufacturing Officer | Leadership |
Jeff Tripp | VP, Site Head | Leadership |
Kerrie Powell | Senior VP, Sales | Leadership |
Guy Kubi | Chief Business Officer | Leadership |
Kimberly McClintock | VP, Marketing & Client Services | Leadership |
12 more people are available in the full profile.
Complete people profiles for Alcami
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alcami
Alcami has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Alcami, Masy BioServices and Triangle Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Non-GMP and GMP pharmaceutical materials are managed across supply chains. | pacificpharmaservices.com | Reno, United States | 2010 | Jan 2024 | •••• | |
Specializes in calibration, qualification and biostorage for life sciences | masy.com | Pepperell, United States | 1984 | Dec 2021 | •••• | |
Nucleoside analogs for HIV & Hepatitis-B | tripharm.com | Staten Island, United States | 1994 | Jan 2020 | •••• |
Complete acquisition details for Alcami
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Alcami
6 dated milestones of Alcami across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Alcami is founded.
- Exit Acquired by MDP.
- Acquisition Acquires Triangle Pharmaceuticals.
- Acquisition Acquires Masy BioServices.
- Exit Acquired by GHO Capital Partners.
- Acquisition Acquires Alcami.
Competitors of Alcami
Alcami has 3 listed competitors in our database, 2 of them funded. They include Asymchem, Aptuit and Continuus Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| aptuit.com | 2004 | Greenwich, United States | $14.23M | Contract research and development services for small molecules are offered. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development |
Detailed competitors of Alcami
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Alcami (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alcami
Complete news archive for Alcami
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alcami
Alcami was founded in 2016.
Alcami is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Stephan Kutzer is the CEO of Alcami, as recorded in our data.
Alcami was established in 2016 through the merger of AAIPharma and Cambridge Major Laboratories. Small molecule development and manufacturing solutions are delivered to pharmaceutical companies in the outsourcing sector. Services encompass formulation, analytical and biopharmaceutical development, analytical testing, oral dose and parenteral manufacturing for final drug products, API manufacturing, as well as packaging and labelling. Operations are headquartered in Wilmington, United States.
Alcami's top competitors include Asymchem, Aptuit and Continuus Pharma.
Alcami offers Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Alcami has made 3 acquisitions, including Alcami, Masy BioServices, and Triangle Pharmaceuticals.
Alcami has 3 investors. Key investors include Madison Dearborn Partners, GHO Capital, and The Vistria Group.
Alcami operates through Alcami Corporation.
Yes. Alcami was acquired by GHO Capital Partners in November 2022.